Bettina Barnicol-Fischer

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Journal: JAMA neurology
Published: August 03, 2026

Retinal layers prognosticate cognitive progression independent of relapse activity in multiple sclerosis.

Retinal layers prognosticate cognitive progression independent of relapse activity in multiple sclerosis.

Journal: Journal of neurology
Published: May 27, 2026

Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 23, 2026

Case Report: Progressive visual decline after optic neuritis associated with microcystic macular oedema.

Case Report: Progressive visual decline after optic neuritis associated with microcystic macular oedema.

Journal: Frontiers in neurology
Published: December 21, 2025

Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis.

Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 19, 2025

Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.

Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.

Journal: Journal of neurology
Published: May 05, 2025

Music therapy with a monochord in multiple sclerosis ("MUTIMS"): A randomized, controlled, rater-blinded trial.

Music therapy with a monochord in multiple sclerosis ("MUTIMS"): A randomized, controlled, rater-blinded trial.

Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: January 27, 2025

Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis.

Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 03, 2025

Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort.

Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort.

Journal: Neurology. Clinical practice
Published: December 04, 2024

Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort.

Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort.

Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: August 28, 2024

Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.

Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.

Journal: Annals of neurology
Published: May 24, 2024

Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.

Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 14, 2024
Showing 1-12 of 22

Last Updated: 09/26/2026